Hyomental Distance Measured Ultrasonography Versus Weight-based Criteria for Laryngeal Mask Size Selection in Children

NCT ID: NCT05832944

Last Updated: 2023-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-30

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* In pediatric surgery and emergencies, LMA represents a useful airway management device for routine and difficult airway management.
* Inserting an improper LMA size may result in malposition, displacement within the hypopharynx, and failed ventilation that needs repositioning.
* Selection of the size of LMA represents a major challenge for anesthesiologists, especially in children.
* The ultrasonographic measured hyomental distance showed a correlation with the length of the pharyngeal cavity.
* Optimization of the size of the inserted LMA can be confirmed either clinically, ultrasonographic or through the fiberoptic laryngoscope.
* The ultrasonographic measured hyomental distance confirmed the optimization of LMA with results comparable to that of the clinical methods and better than those of the fiberoptic laryngoscope.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* The laryngeal mask airway (LMA) is classified as one of the supraglottic devices that have been extensively adopted as an adjunctive or alternative technique to tracheal intubation or mask ventilation for airway management in short-time surgery. Moreover, it is characterized by ease of placement and removal, less injury to the respiratory tract, better tolerability by patients, improved hemodynamic stability, less coughing, less sore throat, avoidance of laryngoscopy, and hands-free airway. However, it is not suitable to overcome functional airway problems and mechanical airway obstruction.
* Although the weight-based method was considered the traditional method for the selection of the optimal LMA size, a clinical practice viewed that this method is not always applicable as there is no linear correlation between the upper airway anatomy and body weight with the presence of usual individual anatomical variation.
* Fortunately, ultrasonography gave high-resolution images of the anatomic structures of the upper airway comparable to computed tomography and magnetic resonance imaging, Ultrasound measurements were applied for the hyomental distance and the hyomental distance ratio. Some studies revealed variable sensitivity and specificity.
* This prospective randomized controlled study will aim to assess the efficacy and safety of ultrasonographic measured hyomental distance in the optimization of the laryngeal mask(LMA)size selection and placement in pediatric patients Operational Design

A) Pre-anaesthetic management:

* Informed written parental consent will be taken from all participants.
* Medical history and complete clinical examination.
* Routine laboratory investigation including :

1. CBC
2. CRP
3. INR, PT \& PTT
* Patients will fast for at least 8 hours before surgery.
* Routine Monitoring, including heart rate (HR), oxygen saturation (SpO2) and noninvasive blood pressure (NIBP) in the pre-anaesthesia room (Base Line Data).
* A peripheral intravenous line (24-22G) will be inserted.
* A premedication of 0.01 mg/kg Atropine will be administrated IM 1 hour before surgery.

B) Induction of general anaesthesia:

* Routine monitoring, including heart rate (HR), oxygen saturation (SpO2), noninvasive blood pressure (NIBP) and continuous electrocardiography (ECG) in the operation room.
* Intravenous induction of anaesthesia will be performed using Propofol 2 mg/kg, and fentanyl 1µg/kg.
* Mechanical Ventilation: 6-8 mL/kg Tidal Volume, 10-20 bpm Respiratory Rate, end-tidal CO2 35-40 mmHg and Volume Controlled ventilation with an inspiratory-expiratory ratio of 1:2 will be initiated.
* For all patients, maintenance of anaesthesia will be performed using Sevoflurane 1-2 %. The depth of anaesthesia will be monitored according to HR.

C) Process:

1. Before starting the current study, a pilot experiment has been done, measuring the upper airway parameters of 10 children who used LMA during operation by ultrasound, investigators found that when the hyomental distance was less than 2 cm, 80% of subjects were suited for class 2 LMA and if 2-3 cm, suited for class 2.5 LMA. Additionally, size 3 LMA were fitted to the hyomental distance above 3 cm.
2. After getting ethical committee approval, and clinical trial registration, 60 pediatric participants will be scheduled for surgery using a laryngeal mask and will be divided randomly into two groups (30 in each group)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laryngeal Mask Airway

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
double-blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group HMD (30 patients)

where the size of LMA will be according to measured hyomental distance by ultrasound as follows:

* If Less than 2 cm: LMA size 2 will be used.
* If 2-3 cm: LMA size 2.5 will be used.
* If more than 3 cm: LMA size 3 will be used.

Group Type EXPERIMENTAL

ultrasound guided hyomental distance

Intervention Type DEVICE

measuring the hyomental distance by ultrasound guidance

Group CONTROL (30 patients)

where size selection will be based on the weight guide

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound guided hyomental distance

measuring the hyomental distance by ultrasound guidance

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parents' acceptance
* Age: between 5-14 years
* Physical Status: American Society of Anesthesiologists (ASA) I \& II)

Exclusion Criteria

* Developmental Delay (mental and physical growth retardation).
* Hypersensitivity to any type of used drugs.
* Patient with a difficult airway ( according to thyromental height and the Mallampati test)
* Patients with a history of neck surgery
* Airway malformation.
* Upper respiratory tract infection.
* Surgeries that will take up to more than forty-five minutes.
Minimum Eligible Age

5 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AHMED ABDELAZIZ SHAMA

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

AHMED A SHAMA, MD

Role: PRINCIPAL_INVESTIGATOR

Assistant professor of anesthesia in Tanta University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

kafrelsheikh university, Faculty of Medicine

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

AHMED A SHAMA, MD

Role: CONTACT

0580925443

SHERIF K ARAFA, MD

Role: CONTACT

0580925443

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sherif k Hafez, MD

Role: primary

00201004397462

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MKSU 51-2-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assessment of Pediatric Challenging Airway
NCT06443424 NOT_YET_RECRUITING